mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.4 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |